March 12, 2024
Meet some of the 227 students in the Class of 2024 at McGovern Medical School at UTHealth Houston who will be together on Friday, March 15, to celebrate Match Day, the day when they learn where they will take the next steps in their careers as physicians.
March 5, 2024
Semaglutide is a safe, effective therapy for a common fatty liver disease in people with HIV, according to the results of a clinical trial presented by UTHealth Houston.
March 1, 2024
Brian Dean, MBA, MPH, a highly respected health care executive with more than 25 years of experience leading health systems across the country, joins UTHealth Houston as executive vice president for health affairs, effective March 18.
February 27, 2024
Three commitments to improve food security, diet quality, and health outcomes for vulnerable communities, made by UTHealth Houston in partnership with local and national organizations, have been approved as part of the White House Challenge to end Hunger and Build Healthy Communities.
February 21, 2024
Across the United States, more babies born at 22 weeks’ gestation are admitted to neonatal intensive care units (NICUs) and surviving in increasing numbers, according to a new study led by UTHealth Houston.
February 19, 2024
UTHealth Houston is a national leader in National Institutes of Health (NIH) research funding, according to annual rankings released by the Blue Ridge Institute for Medical Research.
February 19, 2024
Three faculty members who have demonstrated longstanding excellence in areas of research, teaching, and clinical care, and a fourth recognized for overall exemplary dedication and service, received top honors from UTHealth Houston President Giuseppe N. Colasurdo, MD, Alkek-Williams Distinguished Chair, during a ceremony on Tuesday, Feb. 13.
February 7, 2024
A life-threatening mold infection known as health care-associated Fusarium solani meningitis can be associated with a delayed, but devastating, injury to the brainstem and its blood supply among those infected, according to physicians from UTHealth Houston.
February 1, 2024
As the inaugural dean of UTHealth Houston’s seventh school, Soares will build the school’s platform and infrastructure in preparation for its first students, who are expected to begin coursework in the fall of 2025.
December 18, 2023
The use of high-protease pancreatic replacement therapy demonstrated improvement in maladaptive behaviors, such as irritability, in preschool children with autism spectrum disorder (ASD), according to research conducted at 32 clinical sites, including UTHealth Houston.